Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: ZYMERON CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-06-30 to 2024-01-29
Current total value of award: $250000
Description: DHA SBIR PHASE I NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT